Doctor Sonia Eiras
Health Research Institute, Santiago de Compostela (Spain)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.
Event: ESC Congress 2024
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Antidiabetic drugs for treatment of cardiovascular disease
Epicardial carbohydrate antigen 125 (CA-125) levels, associated with neutrophils activity in heart failure: No differences regarding sex
Event: ESC Congress 2024
Topic: Pathophysiology
Session: Miscellaneous clinical studies in heart failure (2)
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
Event: ESC Congress 2024
Topic: Metabolism
Session: Adipose tissue and other metabolic interactions
Predicting post-operative atrial fibrillation after heart surgery: clinical profile and biomarkers
Event: ESC Congress 2023
Topic: Defining Types of Atrial Fibrillation
Session: Predictors for atrial fibrillation
Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils
Event: ESC Congress 2023
Topic: Leukocytes, Inflammation, Immunity
Session: Inflammatory mechanisms in vascular disease
MUC-16, tumour and congestive heart failure marker, is expressed on epicardial mesothelial cells and is inversely associated with epicardial fat genesis
Event: ESC Congress 2023
Topic: Biomarkers
Session: Elucidating basic mechanisms in heart failure
